These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 17574163

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Better medicines for children: European measures].
    van den Berg H, Taminiau JA.
    Ned Tijdschr Geneeskd; 2008 Jul 05; 152(27):1537-40. PubMed ID: 18681365
    [Abstract] [Full Text] [Related]

  • 3. European perspectives on pediatric formulations.
    Breitkreutz J.
    Clin Ther; 2008 Nov 05; 30(11):2146-54. PubMed ID: 19108802
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Usage of unpublished paediatric data.
    Saint-Raymond A, Pelle B, Zaccaria C, Sennwitz M, Branch S.
    Arch Dis Child; 2016 Jan 05; 101(1):81-4. PubMed ID: 26543071
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J, Puech A, Boissel JP, Participants inRound Table No 7, Giens XXII.
    Therapie; 2007 Jan 05; 62(5):427-35. PubMed ID: 18206104
    [Abstract] [Full Text] [Related]

  • 11. Three years of paediatric regulation in the European Union.
    Olski TM, Lampus SF, Gherarducci G, Saint Raymond A.
    Eur J Clin Pharmacol; 2011 Mar 05; 67(3):245-52. PubMed ID: 21286912
    [Abstract] [Full Text] [Related]

  • 12. Stem cell transplantation in children: how to design a new study.
    Corbacioglu S, EBMT Paediatric Working Party.
    Bone Marrow Transplant; 2008 Jun 05; 41 Suppl 2():S30-4. PubMed ID: 18545241
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization.
    van Luijn JC, Gribnau FW, Leufkens HG.
    Br J Clin Pharmacol; 2007 Feb 05; 63(2):159-62. PubMed ID: 17166187
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug development: EU paediatric legislation, the European Medicines Agency and its Paediatric Committee--adolescents' melanoma as a paradigm.
    Rose K, Senn S.
    Pharm Stat; 2014 Feb 05; 13(4):211-3. PubMed ID: 24903307
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The European paediatric legislation: benefits and perspectives.
    Rocchi F, Paolucci P, Ceci A, Rossi P.
    Ital J Pediatr; 2010 Aug 17; 36():56. PubMed ID: 20716337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.